MITOLA, STEFANIA MARIA FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 13.449
EU - Europa 9.624
AS - Asia 6.184
SA - Sud America 1.088
Continente sconosciuto - Info sul continente non disponibili 388
AF - Africa 150
OC - Oceania 90
Totale 30.973
Nazione #
US - Stati Uniti d'America 13.065
PL - Polonia 5.081
CN - Cina 2.011
SG - Singapore 1.947
IT - Italia 1.154
BR - Brasile 883
UA - Ucraina 828
DE - Germania 633
VN - Vietnam 610
HK - Hong Kong 587
FI - Finlandia 454
GB - Regno Unito 357
FR - Francia 289
IN - India 201
TR - Turchia 190
RU - Federazione Russa 178
CA - Canada 171
IE - Irlanda 163
BD - Bangladesh 155
ID - Indonesia 105
AU - Australia 84
ES - Italia 79
NL - Olanda 72
SE - Svezia 72
AR - Argentina 71
MX - Messico 69
ZA - Sudafrica 50
BE - Belgio 49
IQ - Iraq 49
JP - Giappone 47
CZ - Repubblica Ceca 46
EC - Ecuador 34
AT - Austria 31
PK - Pakistan 30
VE - Venezuela 26
CR - Costa Rica 25
JM - Giamaica 23
CL - Cile 21
IL - Israele 21
MA - Marocco 21
SA - Arabia Saudita 21
UZ - Uzbekistan 20
CO - Colombia 19
MY - Malesia 18
NG - Nigeria 17
AE - Emirati Arabi Uniti 16
CH - Svizzera 16
EG - Egitto 16
HN - Honduras 16
LT - Lituania 16
TW - Taiwan 16
GR - Grecia 15
IR - Iran 15
PH - Filippine 15
JO - Giordania 14
KR - Corea 13
SV - El Salvador 13
DZ - Algeria 12
PY - Paraguay 12
TT - Trinidad e Tobago 12
AZ - Azerbaigian 11
EE - Estonia 11
KE - Kenya 11
GT - Guatemala 10
NI - Nicaragua 9
NP - Nepal 9
AL - Albania 8
BG - Bulgaria 8
HU - Ungheria 8
KG - Kirghizistan 8
NO - Norvegia 8
UY - Uruguay 8
DO - Repubblica Dominicana 7
EU - Europa 7
GP - Guadalupe 7
KZ - Kazakistan 7
PE - Perù 7
RO - Romania 7
DK - Danimarca 6
LK - Sri Lanka 6
OM - Oman 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
BB - Barbados 5
BO - Bolivia 5
ET - Etiopia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
SC - Seychelles 5
TN - Tunisia 5
AM - Armenia 4
BY - Bielorussia 4
LA - Repubblica Popolare Democratica del Laos 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
CW - ???statistics.table.value.countryCode.CW??? 3
HR - Croazia 3
LB - Libano 3
Totale 30.550
Città #
Warsaw 5.073
Ashburn 1.363
Fairfield 1.087
Singapore 1.051
San Jose 850
Woodbridge 720
Houston 692
Jacksonville 615
Hong Kong 581
Ann Arbor 495
Council Bluffs 490
Brescia 481
Seattle 452
Cambridge 421
Beijing 396
Chandler 385
Wilmington 364
New York 286
Princeton 280
Helsinki 277
The Dalles 277
Dong Ket 241
Los Angeles 234
Nanjing 199
Dearborn 198
Dallas 160
Dublin 154
Lauterbourg 144
Istanbul 143
Santa Clara 134
Columbus 129
Munich 120
Ho Chi Minh City 119
Milan 118
São Paulo 108
Buffalo 93
Shanghai 88
Phoenix 87
Jakarta 82
San Francisco 81
Chicago 79
Nanchang 77
Des Moines 75
Hanoi 71
Jinan 70
North Bergen 70
Shenyang 65
Changsha 64
Turku 60
Hebei 59
Orem 57
Boardman 55
Hangzhou 55
Moscow 54
Madrid 51
San Diego 51
London 48
Toronto 48
Brussels 46
Redondo Beach 45
Atlanta 41
Brooklyn 41
Rome 40
Jiaxing 37
Montreal 37
Tianjin 36
Tokyo 36
Chennai 35
Frankfurt am Main 34
Guangzhou 34
Denver 32
Melbourne 31
Stockholm 31
Amsterdam 30
Kunming 30
Johannesburg 29
Nuremberg 29
Zhengzhou 29
Lancaster 28
Boston 27
Haikou 27
Porto Alegre 27
Rio de Janeiro 27
Lappeenranta 25
Springfield 25
Washington 24
Mexico City 23
Manchester 22
Ningbo 22
Poplar 21
Ankara 20
Brno 20
Da Nang 20
Dhaka 20
San José 20
Charlotte 19
Curitiba 19
Lanzhou 19
San Mateo 19
Brasília 18
Totale 21.572
Nome #
Tumor angiogenesis revisited: Regulators and clinical implications 473
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 419
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. 414
Annexin 2A sustains glioblastoma cell dissemination and proliferation. 383
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 382
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 336
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 333
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 332
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 320
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 317
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. 315
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice 315
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 312
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 311
Regulation of dendritic cell migration and adaptive immune response by leukotriene b4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function 311
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 309
Claudin3 is localized outside the tight junctions in human carcinomas 307
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 303
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 300
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 297
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 295
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 289
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 287
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 286
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 285
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. 283
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 281
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 280
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 276
Integrins: A flexible platform for endothelial vascular tyrosine kinase receptors. 269
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 268
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 266
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 266
Interactions between endothelial cells and HIV-1. 264
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 261
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. 261
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 257
Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. 253
Involvement of chemokine receptor4/ cell-derived factor 1 system during osteosarcoma tumor progression 250
Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. 248
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 245
Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. 243
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 241
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 239
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 234
Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. 233
Nitric oxide modulates the angiogenic phenotype of middle-T transformed endothelial cells. 233
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative.Effect on the motility of vascular endothelial cells. 230
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 229
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 229
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 223
Preliminary observations on scleral ossicles in performing functionalized 3D vascularized scaffolds for “critical-size” bone defect healing 222
Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis 221
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 217
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 214
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 212
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 209
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 208
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 206
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 205
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 197
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 196
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 196
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 195
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 193
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 192
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 192
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 190
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 187
Bartonella henselae Persistence within Mesenchymal Stromal Cells Enhances Endothelial Cells Activation and Infectability Amplifying the Angiogenic Process 183
Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. 180
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 179
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 178
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 175
Insights on the receptor dynamics during the spreading of endothelial cells 174
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 174
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 173
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 172
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization 170
Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process 169
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 162
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 161
IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production. 159
CCL16 activates an angiogenic program in vascular endothelial cells 157
Vascular disrupting activity of combretastatin analogues 157
Fibroblast growth factor-2 in angiogenesis 155
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 155
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 154
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 154
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 153
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 153
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 153
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 152
Gremlin as a novel pro-angiogenic VEGFR2 agonist: production of a biologically active recombinant form in S2 Drosophila cells 151
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 151
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 151
Simulation of VEGF receptor recruitment on ECs membrane 151
Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. 150
Role of VEGFs in metabolic disorders 150
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 150
Totale 23.451
Categoria #
all - tutte 119.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.504


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022939 0 0 0 28 37 69 74 72 67 176 103 313
2022/20231.191 198 78 61 69 90 276 22 103 166 15 42 71
2023/20241.607 85 71 154 124 91 243 60 101 295 119 40 224
2024/20253.248 69 25 38 485 363 252 291 141 394 200 572 418
2025/20267.841 650 851 527 1.002 759 535 1.253 372 575 759 401 157
2026/20272.333 373 367 639 954 0 0 0 0 0 0 0 0
Totale 30.973